B-Cell-Delivered Gene Therapy Induces Functional T Regulatory Cells and Leads to a Loss of Antigen-Specific Effector Cells
Authors:
Open Access
- 1 August 2010
- journal article
- research article
- Published by Elsevier in Molecular Therapy
- Vol. 18 (8) , 1527-1535
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Anti-CD3 antibodies modulate anti–factor VIII immune responses in hemophilia A mice after factor VIII plasmid-mediated gene therapyBlood, 2009
- CD4+FOXP3+ regulatory T cells confer long-term regulation of factor VIII–specific immune responses in plasmid-mediated gene therapy–treated hemophilia miceBlood, 2009
- Role of regulatory T cells in tolerance to coagulation factorsJournal of Thrombosis and Haemostasis, 2009
- Cutting Edge: Regulatory T Cells Do Not Require Stimulation through Their TCR to SuppressThe Journal of Immunology, 2009
- How regulatory T cells workNature Reviews Immunology, 2008
- Induction and role of regulatory CD4+CD25+ T cells in tolerance to the transgene product following hepatic in vivo gene transferBlood, 2007
- Regulatory T Cell Lineage Specification by the Forkhead Transcription Factor Foxp3Immunity, 2005
- Retroviral delivery of GAD-IgG fusion construct induces tolerance and modulates diabetes: a role for CD4+ regulatory T cells and TGF-β?Gene Therapy, 2004
- Immunodominant T-cell epitopes in the factor VIII C2 domain are located within an inhibitory antibody binding siteThrombosis and Haemostasis, 2004
- Small B cells as antigen-presenting cells in the induction of tolerance to soluble protein antigens.Journal of Experimental Medicine, 1992